• Lead the end-to-end development and submission of grant applications, with a primary focus on NIH R01 grants.
• Independently shape grant content, including specific aims, study design, methodology, and work plans.
• Work directly with internal scientists and US-based academic and clinical partners to define and align the scientific scope.
• Assess funding opportunities and drive early-stage grant development (concept definition, feasibility, timelines).
• Manage grant timelines, inputs, and submission processes with a high level of autonomy.
• Ensure full compliance with call requirements, formats, and review criteria.
• Coordinate responses to reviewer comments and resubmissions where applicable.
• Maintain clear, structured project communication across stakeholders.

• PhD in medical physics, biomedical imaging, or a closely related field.
• Hands-on research experience with hyperpolarized MRI (HP MRI) is mandatory.
• Strong understanding of medical imaging and translational applications.
• Proven experience contributing to or leading NIH R01 grant applications.
• In-depth knowledge of the US research funding system, particularly NIH processes.
• Proven ability to work independently while collaborating closely with external partners, including advising and supporting customers in strengthening research proposals and grant submissions.
• Strong project management and excellent written and spoken communication skills in English.

• Attractive compensation package, including a competitive base salary and stock options
• Key role in a highly advanced and fast-growing startup company
• Impactful product promoting better understanding and treatment of cancer
• International team, from over 30 different nationalities
• Positive work environment with open communication and a collaborative mindset
• Remote working model
• 30 days PTO
• Flexible working hours
• Relocation support
• Health Insurance Plan, Vision and Dental
• 401K with a 5% employer match

NVision is a quantum biotech startup based in Ulm, Germany, with Tier 1 investors from the USA and Europe. We are just leaving stealth mode, moving from local R&D to global commercialization and expansion.

We are developing a technology that will enable MRI-based imaging of real-time metabolism in the body, with tremendous potential for research and applications in oncology, cardiology, neurology and more. Our company brings together expertise in physics, chemistry, engineering and medicine, and we are collaborating with scientists and clinicians from top medical and research centers such as Memorial Sloan Kettering in New York, MD Anderson in Texas, Technical University of Munich, Cambridge University in the UK and more.

NVision is developing fast, robust and easy-to-use hyperpolarization technology for preclinical and clinical research in our POLARIS product line. Those devices are placed close to an MRI scanner in a research or clinical environment to produce hyperpolarized contrast agents on demand in a fast, fully-automated, multi-step chemical process. Key steps of the process contain fluidic transport across multiple vessels and chemical mixing and separation processes in fully-reuseable or single-use disposable fluid paths. We develop our commercial products jointly with external design and manufacturing partners and the process development as well as the design and manufacturing of prototypes is done entirely in-house.

We offer a dynamic international working environment, with immense room for growth, that encourages personal initiative and open communication.

_